Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Talaris Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income   -63.5-56.8-47.8-40.4-33.8-27.2-22.7
Depreciation and amortization   1.00.80.60.60.50.50.4
Stock-based compensation     2.01.6  1.0
Change in working capital   [+]   4.71.7  1.6
Other operating activities   2.22.00.40.60.90.60.4
Cash from operations   -53.5-47.2-40.0-35.8-30.5-23.0-19.2
   
Capital expenditures   0.5-0.2-1.4-0.5-0.1-0.8-1.3
Purchases of short-term investments, net   92.3184.9179.273.258.0-78.6-132.0
Other cash from investing   -50.1-261.9  -274.2-33.20.0
Cash from investing   42.8-77.3-96.4-201.5-216.2-112.5-133.3
   
Issuance of common stock, net       139.5  
Option exercises   0.30.30.30.1 1.71.6
Other cash from financing   0.3-1.8-1.8-2.9130.8132.8132.8
Cash from financing   0.0137.4137.4136.5268.6131.1131.1
   
Free cash flow   -53.0-47.5-41.4-36.3-30.6-23.8-20.5
        Per share (diluted)   ($1.40)($1.37)($1.59)($1.77)($2.55)($3.51)($3.12)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy